Deyang Fuxin Biomedical Technology Co., Ltd. is a holding company of Zhong Jian Lian Biomedical Technology (Sichuan) Co., Ltd., and engaged in research, promotion, application and technical services of biological mass spectrometry technology and biomedical technology; the third-party medical clinical testing and technical services; the research and development and production and marketing of pharmaceutical equipment; Dr. Sang Ming as the leader of this project is serving as the director of central laboratory of Xiangyang First People’s Hospital affiliated to Hubei University of Medicine, graduated as a doctor from Pathogen Biology Specialty of Medical College of Wuhan University. In 2016, he was funded by the China Scholarship Council to study in Genetics Department of Leicester University; he chaired and participated in the completion of 6 national andprovincial funds, and participated in the national key basic research and development programs (No.973 Program) and the “Twelfth Five-Year Plan”national major special science and technology projects and other major projects.